Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

EpiPen

FDA approves first generic version of EpiPen

Posted August 18, 2018 9:05 pm EST

Updated August 18, 2018 9:11 pm EST

The U.S. Food and Drug Administration has approved the first generic version of Mylan’s EpiPen, made by Teva Pharmaceuticals, which could could help lower the cost of the life-saving allergy injection.

Advertisement

Mom worried about ongoing EpiPen shortage as she gets ready for back to school

Journalistic standards Report an error

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article